Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.45M Sell
14,078
-8,584
-38% -$969K 0.07% 206
2025
Q4
$2.84M Sell
22,662
-108
-0.5% -$13.8K 0.14% 108
2025
Q3
$3.05M Sell
22,770
-22
-0.1% -$2.89K 0.16% 83
2025
Q2
$3.1M Buy
22,792
+294
+1% +$38.8K 0.2% 72
2025
Q1
$2.98M Buy
22,498
+2,867
+15% +$365K 0.24% 69
2024
Q4
$2.22M Buy
19,631
+1,200
+7% +$139K 0.2% 80
2024
Q3
$2.1M Buy
18,431
+287
+2% +$31.5K 0.19% 88
2024
Q2
$1.89M Sell
18,144
-283
-2% -$30K 0.17% 91
2024
Q1
$2.09M Sell
18,427
-15,771
-46% -$1.81M 0.2% 84
2023
Q4
$3.76M Buy
34,198
+25,520
+294% +$2.55M 0.16% 89
2023
Q3
$840K Buy
+8,678
New +$911K 0.1% 119

Other funds holding ABT

Syon Capital's ABT Position: Q1 2026 in Review

Syon Capital reduced its Abbott (ABT) stake by 38% in Q1 2026, selling an estimated $969K and leaving 14,078 shares worth $1.45M. The position accounts for 0.07% of the portfolio, ranked #206.

Syon Capital first reported a position in ABT in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.76M in Q4 2023. 3,087 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Syon Capital held 14,078 shares of Abbott worth $1.45M as of Q1 2026.
  • Syon Capital sold 8,584 Abbott shares in Q1 2026, an estimated $969K.
  • Abbott made up 0.07% of Syon Capital's portfolio in Q1 2026, its #206 holding.
  • Syon Capital first reported a position in Abbott in Q3 2023 and has held it in 11 quarters since.
  • Syon Capital's Abbott position peaked at $3.76M in Q4 2023.
  • 3,087 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.